Ray Kurzweil, the AI scientist and Google researcher, is joining Subsense, a Silicon Valley brain-computer interface startup, as a product and vision advisor1,2.
Subsense develops non-surgical BCI technology that uses inhaled nanoparticles to place computing elements in the brain. The four-year-old company announced the advisory appointment alongside Kurzweil at an event at its Palo Alto, California headquarters on Wednesday evening.
Subsense has raised $27 million in funding. The company is currently conducting pre-clinical work, experimenting with the various elements of its technology and running experiments on mice. Subsense hopes to make the technology available for medical uses and eventually develop it into a consumer product.
In his advisory role, Kurzweil will provide perspective on Subsense's technology roadmap and on how the convergence of AI and neural interfaces will reshape human-computer interactions, according to Fortune.
ANALYSIS The appointment pairs one of the most prominent names in AI futurism with a company whose core technology, inhaled nanoparticles for non-surgical brain-computer interfacing, sits at the intersection of neuroscience, nanotechnology, and artificial intelligence. At the pre-clinical stage with $27 million raised, Subsense remains years from any human application, and Kurzweil's role is advisory rather than operational.